Skip to main content
. 2017 Sep 25;7:12261. doi: 10.1038/s41598-017-12434-z

Figure 4.

Figure 4

Pla2g3 −/− mice are protected against colitis-induced colorectal cancer. (a) Schematic representation of the procedure for the AOM + DSS-induced colon cancer model. (b) Monitoring of survival rates of Pla2g3 −/− and littermate Pla2g3 +/+ mice following repeated DSS challenges. A representative result of three experiments, starting from 12 and 14 Pla2g3 +/+ and Pla2g3 −/− mice, respectively, is shown. (c) Quantitative RT-PCR of inflammation-associated genes in the colons of DSS-treated Pla2g3 +/+ and Pla2g3 −/− mice on day 56 (n = 3 and 9 for Pla2g3 +/+ and Pla2g3 −/− mice, respectively, in one experiment). (d) Gross appearance of the colons in Pla2g3 +/+ and Pla2g3 −/− mice after treatment with AOM + DSS on day 56. (e) Number of large (>2 mm) polyps per mouse in the colons of AOM + DSS-treated Pla2g3 +/+ and Pla2g3 −/− mice on day 56 (n = 23–29; compiled from two experiments). Mean ± SEM, *P < 0.05 and **P < 0.01.